EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effects of intravenous sodium thiosulfate on vascular calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis

Yu-Huan Song, AiBing Ning, Na Guo, Ying Yang, Fei Tang, Na Zhao, Jun Hu, Hong Wu, Ting Peng, Yue-Fei Xiao, Guang-Yan Cai

Cardiovascular Journal of Africa · 2024

DOI: 10.5830/cvja-2023-020 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cardiovascular Journal of Africa, 2024. Verfasst von Yu-Huan Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China. Hauptthemen laut MEDLINE: Thiosulfates, Renal Dialysis, Kidney Failure, Chronic, Vascular Calcification. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In dialysis patients, vascular calcification is a common complication and is closely related to the morbidity and mortality of cardiovascular disease. We performed a systematic review to determine the efficacy and safety of sodium thiosulfate (STS) in the progression of vascular calcification in dialysis patients with end-stage renal disease. METHODS: The PubMed, Web of Science, Embase, Cochrane Library, Wanfang, CNKI, China Biology Medicine disc and Weipu databases were searched up to 9 March 2022 for clinical trials to synthesise findings on the efficacy and safety of STS in the progression of vascular calcification in dialysis patients. The primary outcome was coronary artery calcification scores (CACS) or abdominal aortic calcification scores (AACS) or Kauppila index. The secondary outcome was pulse-wave velocity (PWV). Laboratory data were shown in safety data. A random-effect model was used to provide the summary measures of effect [standardised mean difference (SMD) and 95% confidence interval (CI)]. RESULTS: Seven randomised, controlled trials and one nonrandomised, controlled trial involving 370 patients were included. Six studies reported that the progression of CACS or AACS was slower in the intravenous STS group compared with the control group (SMD -3.24, 95% CI: -5.29, -1.18, p = 0.002). Two studies showed the increase in PWV was less in the STS group compared with the control group (SMD -0.52, 95% CI: -0.92, -0.13, p = 0.009). During the trial period, a lower high-sensitivity C-reactive protein level (SMD 1.61, 95% CI: 0.19, 3.04, p = 0.03), a decrease in serum bicarbonate level (SMD 0.67, 95% CI: 0.22, 1.11, p = 0.003) and an increase in serum phosphate level (SMD -0.32, 95% CI: -0.62, -0.03, p = 0.03) were noted in the intravenous STS group compared with the control group. However, serum calcium and parathyroid hormone levels showed no difference between the two groups after the trials. The most common adverse events were temporary nausea and vomiting, which occurred in 12.5 to 75% of patients. CONCLUSIONS: Intravenous STS may slow down the progression of vascular calcification and ameliorate arterial stiffness in dialysis patients. Reliably defining the efficacy and safety of intravenous STS in attenuating the progression of vascular calcification requires a high-quality trial with a large sample size.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiosulfatesRenal DialysisKidney Failure, ChronicVascular CalcificationCoronary Artery DiseaseChelating AgentsAortic DiseasesHumansTreatment OutcomeDisease ProgressionFemaleMaleMiddle AgedAgedAdultRisk FactorsInfusions, IntravenousTime FactorsRisk AssessmentAdministration, Intravenous

Stichwörter der Autor:innen

dialysissodium thiosulfatevascular calcification

Substanzen

Thiosulfatessodium thiosulfateChelating Agents

Autor:innen und Institutionen

  • Department of Nephrology, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.
  • Department of Library, Gansa Medical College, Pingliang, Gansu, China. Email: 64807184@qq.com.
  • Centre for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, China.
  • Department of Nephrology, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China. Email: caiguangyan@sina.com.

Zitieren

APA

Song, Y. H., Ning, A., Guo, N., Yang, Y., Tang, F., Zhao, N., Hu, J., Wu, H., Peng, T., Xiao, Y. F., & Cai, G. Y. (2024). Effects of intravenous sodium thiosulfate on vascular calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis. Cardiovascular Journal of Africa. https://doi.org/10.5830/cvja-2023-020

Vancouver

Song YH, Ning A, Guo N, Yang Y, Tang F, Zhao N, et al. Effects of intravenous sodium thiosulfate on vascular calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis. Cardiovascular Journal of Africa. 2024. doi:10.5830/cvja-2023-020

BibTeX
@article{Song2024,
  author = {Song, Yu-Huan and Ning, AiBing and Guo, Na and Yang, Ying and Tang, Fei and Zhao, Na and Hu, Jun and Wu, Hong and Peng, Ting and Xiao, Yue-Fei and Cai, Guang-Yan},
  title = {Effects of intravenous sodium thiosulfate on vascular calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis},
  journal = {Cardiovascular Journal of Africa},
  year = {2024},
  doi = {10.5830/cvja-2023-020}
}
Kostenlos starten →